RAO DAVULURI RAMAMOHAN has a total of 15 patent applications. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and chemical engineering are WUGAN PHARMACEUTICAL SUZHOU CO LTD, CATALYTICA PHARMACEUTICALS INC and XIAMEN LAIENSITE INFORMATION TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Ravi Ponnaiah | 11 |
#2 | Rajput Vishal | 7 |
#3 | Neela Praveen Kumar | 7 |
#4 | Anilkumar Bondada | 7 |
#5 | Dhanunjaya Mailapalli | 7 |
#6 | Rao Davuluri Ramamohan | 5 |
#7 | Naresh Dongari | 4 |
#8 | Ponnaiah Ravi | 3 |
#9 | Guruswamy Bathini | 3 |
#10 | Rao Narayana Venugopala | 3 |
Publication | Filing date | Title |
---|---|---|
US2015232430A1 | 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2(2-pyrimidinyl)-pyrimidine-4-yl)-benzen esulfonamide sodium | |
EP2872500A2 | An improved process for the preparation of dabigatran etexilate mesylate and its intermediates thereof | |
WO2013179297A1 | Process for preparation of (1s, 3s, 5s)-2-[(2s)-2-amino-2-(3-hydroxy-1-adamantyl) acetyl]-2-azabicyclo [3.1.0] hexane-3-carbonitrile | |
WO2013132514A2 | Novel processes for preparation of (r)-5-[2-[(5,6-diethyl-2,3-dihydro-lh-rnden-2-yl)amino]-l- hydroxyethylj-8-hydroxy quinolin-2(lh)-one |